Immune Tolerance Network
Business Services · Washington, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1201 9th Ave, Seattle, Washington, 98101...Phone Number
(206) 342-6901Website
www.immunetolerance.orgRevenue
$27 MillionIndustry
About Immune Tolerance Network
The Immune Tolerance Network focuses on developing, funding, and conducting clinical trials aimed at achieving immune tolerance in various medical conditions, including autoimmune diseases, allergies, and transplantation. Their research seeks to induce tolerance of transplanted organs without the need for lifelong immunosuppression and to achieve durable desensitization to allergens. The organization collaborates with researchers and patients to advance the clinical application of immune tolerance therapies. Their intended clients include patients with autoimmune diseases, allergies, and those requiring organ transplants.Explore more
SIC Code 87,873NAICS Code 54,541Show moreImmune Tolerance Network Org Chart
Compare Similar Companies to Immune Tolerance Network
Compare insights from companies similar to Immune Tolerance Network, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Immune Tolerance Network
$27M
51-200
Private
-
1999
DS
Dawn SmilekGroup Chief Medical Officer, Clinical Trials
<$5M
51-200
Private
-
2000
JC
Jeannette CassarGroup Associate Director, Research Teams, Trial Operations
Immune Tolerance Network Tech Stack
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Immune Tolerance Network
Sign Up For FreeTo access detailed company insights
The Immune Tolerance Network focuses on developing, funding, and conducting clinical trials aimed at achieving immune tolerance in various medical conditions, including autoimmune diseases, allergies, and transplantation. Their research seeks to induce tolerance of transplanted organs without the need for lifelong immunosuppression and to achieve d... Read More